We provide you with 20 years of free, institutional-grade data for LMNL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LMNL. Explore the full financial landscape of LMNL stock.
| Reported Date | CIK | Ticker | Type |
|---|
Liminal BioSciences Inc(NASDAQ:LMNL) 
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high...
Website: http://www.liminalbiosciences.com
Founded: 1994
Full Time Employees: 300
CEO: Kenneth Harry Galbraith
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about LMNL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.